Trilobatin attenuates cerebral ischaemia/reperfusion‐induced blood–brain barrier dysfunction by targeting matrix metalloproteinase 9: The legend of a food additive
British Journal of Pharmacology · 2024
DOI: 10.1111/bph.16239 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2024. Verfasst von Linying Feng und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau SAR, China. Hauptthemen laut MEDLINE: Brain Ischemia, Reperfusion Injury, Flavonoids, Polyphenols. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Collaborative Innovation Center of Chinese Ministry of Education, Natural Science Foundation of China, Science and Technology Program of Guizhou Province.
Abstract (Originalsprache)
Background and Purpose Blood–brain barrier (BBB) breakdown is one of the crucial pathological changes of cerebral ischaemia–reperfusion (I/R) injury. Trilobatin (TLB), a naturally occurring food additive, exerts neuroprotective effects against cerebral I/R injury as demonstrated in our previous study. This study was designed to investigate the effect of TLB on BBB disruption after cerebral I/R injury. Experimental Approach Rats with focal cerebral ischaemia caused by transient middle cerebral artery occlusion were studied along with brain microvascular endothelial cells and human astrocytes to mimic BBB injury caused by oxygen and glucose deprivation/reoxygenation (OGD/R). Key Results The results showed that TLB effectively maintained BBB integrity and inhibited neuronal loss following cerebral I/R challenge. Furthermore, TLB increased tight junction proteins including ZO‐1, Occludin and Claudin 5, and decreased the levels of apolipoprotein E (APOE) 4, cyclophilin A (CypA) and phosphorylated nuclear factor kappa B (NF‐κB), thereby reducing proinflammatory cytokines. TLB also decreased the Bax/Bcl‐2 ratio and cleaved‐caspase 3 levels along with a reduced number of apoptotic neurons. Molecular docking and transcriptomics predicted MMP9 as a prominent gene evoked by TLB treatment. The protective effects of TLB on cerebral I/R‐induced BBB breakdown was largely abolished by overexpression of MMP9, and the beneficial effects of TLB on OGD/R‐induced loss of BBB integrity in human brain microvascular endothelial cells and astrocyte co‐cultures was markedly reinforced by knockdown of MMP9. Conclusions and Implications Our findings reveal a novel property of TLB: preventing BBB disruption following cerebral I/R via targeting MMP9 and inhibiting APOE4/CypA/NF‐κB axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau SAR, China.
- Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi, China.
- The Collaborative Innovation Center of Tissue Damage Repair and Regeneration Medicine of Zunyi Medical University, Zunyi, China.
ORCID-Profile: Zhu Yi Zhun
Förderung
- Collaborative Innovation Center of Chinese Ministry of Education
- Natural Science Foundation of China
- Science and Technology Program of Guizhou Province
- National Natural Science Foundation of China
- Science and Technology Innovation Team of Higher Education of Guizhou Provincial Education Department
- The future 'techelite' talent development program from Zunyi Medical University
- Guizhou Province Science and Technology Planning project of Zunyi
- Science and Technology Planning project of Zunyi
Zitieren
APA
Feng, L., Li, Y., Lin, M., Xie, D., Luo, Y., Zhang, Y., He, Z., Gong, Q., Zhun, Z. Y., & Gao, J. (2024). Trilobatin attenuates cerebral ischaemia/reperfusion‐induced blood–brain barrier dysfunction by targeting matrix metalloproteinase 9: The legend of a food additive. British Journal of Pharmacology. https://doi.org/10.1111/bph.16239
Vancouver
Feng L, Li Y, Lin M, Xie D, Luo Y, Zhang Y, et al. Trilobatin attenuates cerebral ischaemia/reperfusion‐induced blood–brain barrier dysfunction by targeting matrix metalloproteinase 9: The legend of a food additive. British Journal of Pharmacology. 2024. doi:10.1111/bph.16239
BibTeX
@article{Feng2024,
author = {Feng, Linying and Li, Yeli and Lin, Mu and Xie, Dianyou and Luo, Yunmei and Zhang, Yuandong and He, Zhixu and Gong, Qihai and Zhun, Zhu Yi and Gao, Jianmei},
title = {Trilobatin attenuates cerebral ischaemia/reperfusion‐induced blood–brain barrier dysfunction by targeting matrix metalloproteinase 9: The legend of a food additive},
journal = {British Journal of Pharmacology},
year = {2024},
doi = {10.1111/bph.16239}
}
EUVIMED